In addition, it increased caspase-3 activities and PARP cleavage in all three cell lines and promoted G2/M phase cell cycle arrest in PCa cells by suppressing cdc2 and cdc25C phosphorylation. The gene discussed is CASP3; the disease is posterior cortical atrophy.